LEO Pharma - Resultados da pesquisa

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

picato ingenol mebutate 0.015% (w/w) gel tube

leo pharma pty ltd - ingenol mebutate -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

picato ingenol mebutate 0.05% (w/w) gel tube

leo pharma pty ltd - ingenol mebutate -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

enstilar calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can

leo pharma pty ltd - calcipotriol, quantity: 20.5 microgram/g; betamethasone dipropionate, quantity: 264 microgram/g (equivalent: betamethasone, qty 205 microgram/g) - foam - excipient ingredients: polyoxypropylene-11 stearyl ether; liquid paraffin; dl-alpha-tocopherol; white soft paraffin; butane; methyl ether - enstilar is indicated for the topical treatment of psoriasis vulgaris in adults.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

daivobet 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment tube

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g; betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty 500 microgram/g) - ointment - excipient ingredients: liquid paraffin; polyoxypropylene-11 stearyl ether; dl-alpha-tocopherol; white soft paraffin; butylated hydroxytoluene - daivobet ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy.